The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: Review and technical considerations

Plastic and Reconstructive Surgery

Volumn 120, Issue 6 S SUPPL., 2007, Pages

  Rohrich, Rod J ^a   Ghavami, Ashkan ^a   Crosby, Melissa A ^a  

^a Department of Plastic Surgery ^*

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; FILLER; HYALURONIC ACID;

DRUG EFFICACY; DRUG SAFETY; ESTHETIC SURGERY; HUMAN; LONGEVITY; PRIORITY JOURNAL; REJUVENATION; REVIEW; SKIN TEST; SURGICAL TECHNIQUE; TREATMENT PLANNING; UNIVERSITY HOSPITAL;

EID: 85042586232     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000248794.63898.0f     Document Type: Review

References (36)

1. American Society of Plastic Surgeons. 2003 Statistics. Arlington Heights, Ill.: American Society of Plastic Surgeons. Available at http://www. platicsurgery.org/public_education/loader.cfm?url=/commonspot/security/getfile. cfm&PageID=12552. Accessed August 8, 2007.
2. Rohrich, R. J., Rios, J. L., and Fagien, S. Role of new fillers in facial rejuvenation: A cautious outlook. Plast. Reconstr. Surg. 112: 1899, 2003.
3. Duranti, F., Salti, G., Bovani, B., et al. Injectable hyaluronic acid gel for soft tissue augmentation: A clinical and histological study. Dermatol. Surg. 24: 1317, 1998.
4. Laurent, T. C. Biochemistry of hyaluronan. Acta Otolaryngol. Suppl. 442: 7, 1987.
5. Devore, D. P., Hughes, E., and Scott, J. B. Effectiveness of injectable filler materials for smoothing wrinkle lines and depressed scars. Med. Prog. Technol. 20: 243, 1994.
6. Longas, M. O., Russell, C. S., and He, X. Y. Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging. Carbohydr. Res. 159: 127, 1987.
7. Balasz, E. A., Bland, P. A., Denlinger, J. L., et al. Matriz engineering. Blood Coagul. Fibrinolysis 2: 173, 1991.
8. Balasz, E. A., Leshchiner, E., Larsen, N. E., et al. Hyaluronan biomaterials: Medical application. In D. L. Wise (Ed.), Handbook of Biomaterials and Application. New York: Dekker, 1995. Pp. 2719-2741.
9. Larsen, N. E., Pollak, C. T., Reiner, K., et al. Hylan gel biomaterial: Dermal and immunological compatibility. J. Biomed. Mater. Res. 27: 1129, 1993.
10. Laurent, T.C., and Fraser, J. R. Hyaluronan. FASEB J. 6:2397, 1992.
11. Q-Med AB. Restylane (Investigators Brochure). Uppsala, Sweden: Q-Med AB, 1996.
12. Melton, J. L., and Hanke, C. N. Soft tissue augmentation. In R. K. Roenigk and H. H. Roenigk (Eds.), Dermatologic Surgery: Principles and Practice. New York: Dekker, 1996. Pp. 1077-1087.
13. Captique (Package Insert). Santa Barbara, Calif.: Allergan, Inc. 2004. Available at http://facialplasticsurgery.lookingyourbest.com/articles/ captique_faq.php. Accessed August 8, 2007.
14. U.S. Food and Drug Administration. Restylane. Available at www.fda.gov/cdrh/pdf4/p040024.html. Washington, D.C.: Food and Drug Administration. Accessed August 9, 2007.
15. U.S. Food and Drug Administration. Hylaform. Available at www.fda.gov/cdrh/mda/docs/p030032.html. Washington, D.C.: Food and Drug Administration. Accessed August 9, 2007.
16. Olenius, M. The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles, and folds. Aesthetic Plast. Surg. 22: 97, 1998.
17. Narins, R. S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol. Surg. 29: 588, 2003.
18. Restylane (Package Insert). Scottsdale, Ariz.: Medicis Aesthetics Holdings, Inc. 2003.
19. Restylane. Scottsdale, Ariz.: Medicis Aesthetics Holdings, Inc. Available at http://restylaneusa.com. Accessed August 9, 2007.
20. Hylaform (Package Insert). Santa Barbara, Calif.: Inamed. 2004.
21. Hylaform Plus (Package Insert). Santa Barbara, Calif.: Allergan, Inc. 2004.
22. Allergan/Inamed Web site. Available at http://www.allerganandinamed.com. Accessed August 9, 2007.
23. Carruthers, J., and Carruthers, A. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: Treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol. Surg. 29: 802, 2003.
24. Fitzpatrick, R. E., Goldman, M. P., Satur, N. M., and Tope, W. D. Pulsed carbon dioxide laser resurfacing of photo-aged facial skin. Arch. Dermatol. 132: 395, 1996.
25. Glogau, R. G. Aesthetic and anatomic analysis of the aging skin. Semin. Cutan. Med. Surg. 15: 134, 1996.
26. Lemperle, G., Holmes, R. E., Cohen, S. R., and Lemperle, S. M. A classification of facial wrinkles. Plast. Reconstr. Surg. 108: 1735, 2001.
27. Friedman, P. M., Mafong, E. A., Kauvar, A. N., and Geronemus, R. G. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol. Surg. 28: 291, 2002.
28. Manna, F., Dentiui, M., Desisen, P., Depita, A., Mortilla, E., and Maras, B. Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (Hylaform from rooster combs and Restylane from Streptococcus) used for soft tissue augmentation. J. Eur. Acad. Dermatol. Venereol. 13: 183, 1999.
29. Fernandez-Acenero, M., Zamora, E., and Borbujo, J. Granulomatous foreign body reaction against hyaluronic acid: Report of a case after lip augmentation. Dermatol. Surg. 29: 12, 2003.
30. Brody, H. J. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol. Surg. 31: 8, 2005.
31. Lambros, V. The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast. Reconstr. Surg. 114: 277, 2004.
32. Micheels, P. Human anti-hyaluronic acid antibodies: Is it possible? Dermatol. Surg. 27: 2, 2001.
33. Lupton, J. R., and Alster, T. S. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol. Surg. 26: 2, 2000.
34. Vartanian, A. J., Frankel, A. S., and Rubin, M. G. Injected hyaluronidase reduces Restylane-mediated cutaneous augmentation. Arch. Facial Plast. Surg. 7: 231, 2005.
35. McEvoy, G. K. (Ed.). Hyaluronidase. In AHFS Drug Information 2001. Bethesda, Md.: American Society of Health-Systems Pharmacists, 2001. P. 2602.
36. Shafir, R., Amir, A., and Gur, E. Long-term complications of facial injection with Restylane. Plast. Reconstr. Surg. 106: 1215, 2000.